HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy
暂无分享,去创建一个
Eneida A. Mendonça | Amy K. Erbe | A. Naranjo | J. Maris | KyungMann Kim | E. Mendonça | W. London | M. Hogarty | A. Yu | Jeffrey S. Miller | F. Hong | Julie R. Park | L. Carmichael | J. Hank | P. Sondel | A. Erbe | A. Yu | M. Ozkaynak | B. Kahl | Wei Wang | Yiqiang Song | P. Reville | A. Gilman | Kyung Mann Kim | Julie R. Park | Alice L. Yu